Ads
related to: nhs guidelines for multiple sclerosis patients in florida today chart- Dosing & Administration
Discover Dosing Information
For This Treatment.
- Mechanism Of Action
View This Informational Video
About This Treatment's MOA.
- Starting Treatment
Download These Resources To
Help Your Patients Get Started.
- Patient Support Services
See Information On Our
Patient Support Program.
- Discover Efficacy Data
Explore Clinical Trial And
Efficacy Data.
- Patient Profiles
See If This Treatment May
Be Right For Your RMS Patients.
- Dosing & Administration
Search results
Results From The WOW.Com Content Network
The McDonald criteria are diagnostic criteria for multiple sclerosis (MS). These criteria are named after neurologist W. Ian McDonald who directed an international panel in association with the National Multiple Sclerosis Society (NMSS) of America and recommended revised diagnostic criteria for MS in April 2001.
In March 2017, ocrelizumab was approved in the United States for the treatment of primary progressive multiple sclerosis in adults. [22] [42] It is also used for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. [42]
Main symptoms of multiple sclerosis Symptoms and findings in multiple sclerosis. Multiple sclerosis can cause a variety of symptoms varying significantly in severity and progression among individuals: changes in sensation (hypoesthesia), muscle weakness, abnormal muscle spasms, or difficulty moving; difficulties with coordination and balance; problems in speech or swallowing (), visual ...
Multiple sclerosis. Multiple sclerosis is an autoimmune disease, primarily mediated by T-cells. [15] The three main characteristics of MS are the formation of lesions in the central nervous system (also called plaques), inflammation, and the destruction of myelin sheaths of neurons.
The Patient Reported Outcome Indices for Multiple Sclerosis (PRIMUS) is a disease specific patient-reported outcome questionnaire which measures the quality of life (QoL) of patients with multiple sclerosis. [1] The measure contains an assessment of quality of life, activity limitations and symptoms.
Nearly 2.3 million people are estimated to be living with multiple sclerosis around the world, but when Montel Williams received his official diagnosis back in 1999, not much was known about the ...
Ads
related to: nhs guidelines for multiple sclerosis patients in florida today chart